Log in
NASDAQ:ADVM

Adverum Biotechnologies News Headlines

$10.81
+0.31 (+2.95 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$10.43
Now: $10.81
$10.91
50-Day Range
$10.50
MA: $13.11
$18.70
52-Week Range
$4.96
Now: $10.81
$26.98
Volume1.66 million shs
Average Volume1.43 million shs
Market Capitalization$871.90 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Headlines

Adverum Biotechnologies (NASDAQ ADVM) News Headlines Today

Source:
DateHeadline
BidaskClub Lowers Adverum Biotechnologies (NASDAQ:ADVM) to SellBidaskClub Lowers Adverum Biotechnologies (NASDAQ:ADVM) to Sell
marketbeat.com - September 26 at 2:07 AM
Raymond James Reiterates Hold Rating for Adverum Biotechnologies (NASDAQ:ADVM)Raymond James Reiterates Hold Rating for Adverum Biotechnologies (NASDAQ:ADVM)
marketbeat.com - August 26 at 7:12 AM
Adverum Biotechnologies (NASDAQ:ADVM) Downgraded by BidaskClub to SellAdverum Biotechnologies (NASDAQ:ADVM) Downgraded by BidaskClub to Sell
marketbeat.com - August 15 at 5:17 AM
Adverum Biotechnologies (NASDAQ:ADVM) Rating Increased to Buy at BidaskClubAdverum Biotechnologies (NASDAQ:ADVM) Rating Increased to Buy at BidaskClub
marketbeat.com - May 8 at 3:28 AM
Comparing TRACON Pharmaceuticals (NASDAQ:TCON) & Adverum Biotechnologies (NASDAQ:ADVM)Comparing TRACON Pharmaceuticals (NASDAQ:TCON) & Adverum Biotechnologies (NASDAQ:ADVM)
americanbankingnews.com - September 24 at 10:05 AM
Adverum Biotechnologies (NASDAQ:ADVM) Trading Down 6.8%Adverum Biotechnologies (NASDAQ:ADVM) Trading Down 6.8%
americanbankingnews.com - September 21 at 9:20 PM
Adverum Biotechnologies Inc (NASDAQ:ADVM) Given Average Recommendation of "Buy" by BrokeragesAdverum Biotechnologies Inc (NASDAQ:ADVM) Given Average Recommendation of "Buy" by Brokerages
americanbankingnews.com - September 20 at 2:46 AM
Adverum Biotechnologies Announces Appointment of Christopher J. Morrison, Ph.D. as Vice President, Process ScienceAdverum Biotechnologies Announces Appointment of Christopher J. Morrison, Ph.D. as Vice President, Process Science
finance.yahoo.com - September 15 at 12:59 PM
Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Up 6.8%Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Up 6.8%
americanbankingnews.com - September 14 at 8:44 PM
Adverum Biotechnologies to Participate in the Cantor Virtual Global Healthcare ConferenceAdverum Biotechnologies to Participate in the Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 12 at 1:02 AM
Adverum Biotechnologies to Participate in the Cantor Virtual Global Healthcare ConferenceAdverum Biotechnologies to Participate in the Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 10 at 8:47 AM
New Strong Sell Stocks for September 8thNew Strong Sell Stocks for September 8th
finance.yahoo.com - September 8 at 9:42 AM
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Increased Their HoldingsAdverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Increased Their Holdings
finance.yahoo.com - August 20 at 10:13 AM
Adverum Biotechnologies Announces Closing of $217 Million Public Offering of Common StockAdverum Biotechnologies Announces Closing of $217 Million Public Offering of Common Stock
finance.yahoo.com - August 18 at 9:09 AM
Adverum (ADVM) Surges: Stock Moves 6.2% HigherAdverum (ADVM) Surges: Stock Moves 6.2% Higher
finance.yahoo.com - August 17 at 2:01 PM
Oversold Conditions For Adverum Biotechnologies (ADVM)Oversold Conditions For Adverum Biotechnologies (ADVM)
nasdaq.com - August 13 at 2:10 PM
Adverum Bio raises $189M via public offeringAdverum Bio raises $189M via public offering
seekingalpha.com - August 13 at 8:36 AM
Adverums gene therapy shows encouraging action in wet AMD studyAdverum's gene therapy shows encouraging action in wet AMD study
seekingalpha.com - August 11 at 5:19 PM
Adverum Biotechnologies, Inc. (ADVM) Q2 2020 Earnings Call TranscriptAdverum Biotechnologies, Inc. (ADVM) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 11 at 5:19 PM
Adverum Biotechnologies Announces $200 Million Public Offering of Common StockAdverum Biotechnologies Announces $200 Million Public Offering of Common Stock
finance.yahoo.com - August 11 at 5:19 PM
Adverum Biotechnologies EPS misses by $0.06, beats on revenueAdverum Biotechnologies EPS misses by $0.06, beats on revenue
seekingalpha.com - August 10 at 7:07 PM
Notable Thursday Option Activity: BEAT, ADVM, MSFTNotable Thursday Option Activity: BEAT, ADVM, MSFT
www.nasdaq.com - July 30 at 6:19 PM
Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Provide Corporate UpdateAdverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - July 29 at 7:40 PM
How this outspoken, gay biotech CEO landed at a gene therapy companyHow this outspoken, gay biotech CEO landed at a gene therapy company
www.bizjournals.com - July 27 at 2:40 PM
Adverum Biotechnologies Announces Appointment of Thomas Kochy as Vice President, Commercial and Program StrategyAdverum Biotechnologies Announces Appointment of Thomas Kochy as Vice President, Commercial and Program Strategy
finance.yahoo.com - July 21 at 9:44 AM
Did Hedge Funds Make The Right Call On Adverum Biotechnologies, Inc. (ADVM)Did Hedge Funds Make The Right Call On Adverum Biotechnologies, Inc. (ADVM)
finance.yahoo.com - July 20 at 1:11 PM
Did Hedge Funds Make The Right Call On Adverum Biotechnologies, Inc. (ADVM) ?Did Hedge Funds Make The Right Call On Adverum Biotechnologies, Inc. (ADVM) ?
finance.yahoo.com - July 20 at 1:11 PM
Dosing underway in Adverum Bios Infinity trial of ADVM-022 for diabetic macular edemaDosing underway in Adverum Bio's Infinity trial of ADVM-022 for diabetic macular edema
seekingalpha.com - July 13 at 10:20 AM
Adverum Biotechnologies Announces First Patient Randomized in Phase 2 INFINITY Trial of ADVM-022 Single Injection Gene Therapy for Diabetic Macular Edema (DME)Adverum Biotechnologies Announces First Patient Randomized in Phase 2 INFINITY Trial of ADVM-022 Single Injection Gene Therapy for Diabetic Macular Edema (DME)
finance.yahoo.com - July 13 at 10:20 AM
Adverum Biotechnologies Announces Completion of Patient Dosing in Cohort 4 of the OPTIC Phase 1 Trial of ADVM-022 Single Injection Gene Therapy for Wet AMDAdverum Biotechnologies Announces Completion of Patient Dosing in Cohort 4 of the OPTIC Phase 1 Trial of ADVM-022 Single Injection Gene Therapy for Wet AMD
finance.yahoo.com - July 6 at 11:18 AM
Edited Transcript of ADVM earnings conference call or presentation 28-May-20 8:30pm GMTEdited Transcript of ADVM earnings conference call or presentation 28-May-20 8:30pm GMT
finance.yahoo.com - June 30 at 10:06 PM
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEOThe Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
finance.yahoo.com - June 18 at 8:22 PM
New chief at Adverum BioNew chief at Adverum Bio
seekingalpha.com - June 15 at 6:24 PM
Adverum Biotechnologies Announces Leadership TransitionAdverum Biotechnologies Announces Leadership Transition
finance.yahoo.com - June 15 at 6:24 PM
Hedge Funds Are Betting On Adverum Biotechnologies, Inc. (ADVM)Hedge Funds Are Betting On Adverum Biotechnologies, Inc. (ADVM)
finance.yahoo.com - June 15 at 1:23 PM
Relative Strength Alert: Will the Adverum Biotechnologies Inc (NMQ:ADVM) share price keep rising?Relative Strength Alert: Will the Adverum Biotechnologies Inc (NMQ:ADVM) share price keep rising?
uk.finance.yahoo.com - June 15 at 8:22 AM
Adverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Call TranscriptAdverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 29 at 12:55 PM
Adverum Biotechnologies, Inc. (ADVM) CEO Leone Patterson on Q1 2020 Results - Earnings Call TranscriptAdverum Biotechnologies, Inc. (ADVM) CEO Leone Patterson on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 29 at 12:47 AM
Adverum Biotechnologies EPS misses by $0.04Adverum Biotechnologies EPS misses by $0.04
seekingalpha.com - May 28 at 7:46 PM
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - May 25 at 2:47 PM
Adverum Biotechnologies to Host a Conference Call and Webcast to Report First Quarter 2020 Financial Results and Provide Corporate UpdateAdverum Biotechnologies to Host a Conference Call and Webcast to Report First Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - May 21 at 5:49 PM
Is Adverum Biotechnologies (ADVM) Outperforming Other Medical Stocks This Year?Is Adverum Biotechnologies (ADVM) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 7 at 3:08 PM
Here's Why Adverum Biotechnologies Is Soaring TodayHere's Why Adverum Biotechnologies Is Soaring Today
finance.yahoo.com - May 7 at 4:45 AM
Why Adverum Biotechnologies Stock Is Soaring TodayWhy Adverum Biotechnologies Stock Is Soaring Today
finance.yahoo.com - May 5 at 5:27 PM
Small Biotech Rockets To 5-Year High On Regeneron-Rivaling Gene TherapySmall Biotech Rockets To 5-Year High On Regeneron-Rivaling Gene Therapy
finance.yahoo.com - May 5 at 5:27 PM
Adverum gene therapy shows positive action in wet AMD; shares up 22% premarketAdverum gene therapy shows positive action in wet AMD; shares up 22% premarket
seekingalpha.com - May 5 at 8:50 AM
BRIEF-Adverum Biotech Reports Positive Interim Data From Cohorts 1-3 Of Optic Phase 1 Trial Of Advm-022 Intravitreal Gene Therapy For Wet AMDBRIEF-Adverum Biotech Reports Positive Interim Data From Cohorts 1-3 Of Optic Phase 1 Trial Of Advm-022 Intravitreal Gene Therapy For Wet AMD
www.reuters.com - May 4 at 10:49 PM
Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMDAdverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
www.benzinga.com - May 4 at 5:49 PM
Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMDAdverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
finance.yahoo.com - May 4 at 5:49 PM
Adverum Biotechnologies Announces Virtual Presentations of Data through ASGCT and ARVOAdverum Biotechnologies Announces Virtual Presentations of Data through ASGCT and ARVO
finance.yahoo.com - April 30 at 8:43 PM
Heres Why Momentum Investors Will Love Adverum Biotechnologies (ADVM)Here's Why Momentum Investors Will Love Adverum Biotechnologies (ADVM)
www.nasdaq.com - April 28 at 5:00 PM
Adverum Biotechnologies to Host a Conference Call and Webcast to Present New Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMDAdverum Biotechnologies to Host a Conference Call and Webcast to Present New Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD
finance.yahoo.com - April 27 at 7:49 PM
BRIEF-Adverum Biotechnologies Doses First Patient In Cohort 4 Of OPTIC Phase 1 Clinical Trial Of ADVM-022BRIEF-Adverum Biotechnologies Doses First Patient In Cohort 4 Of OPTIC Phase 1 Clinical Trial Of ADVM-022
www.reuters.com - April 27 at 9:47 AM
Adverum Biotechnologies Doses First Patient in Cohort 4 of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMDAdverum Biotechnologies Doses First Patient in Cohort 4 of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
finance.yahoo.com - April 27 at 9:47 AM
This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.